Protective effect of plasma neutralization from prior SARS-CoV-2 Omicron infection against BA.5 subvariant symptomatic reinfection

Lancet Reg Health West Pac. 2023 Apr:33:100758. doi: 10.1016/j.lanwpc.2023.100758. Epub 2023 Mar 31.

Xiaosu Chen¹, Yanli Xu², Yan Xie³, Weiliang Song^{4

5

6}, Ye Hu¹, Ayijiang Yisimayi^{4

5

6}, Sijie Yang^{4

5

7}, Fei Shao⁴, Li Geng⁸, Ying Wang⁹, Hongmei Gao¹⁰, Yansong Shi¹, Shuo Zhang¹¹, Ronghua Jin², Zhongyang Shen¹², Yunlong Cao^{4

5

6}

¹ Frontier Research Center for Cell Response, Institute of Immunology, College of Life Sciences, Nankai University, Tianjin, PR China.
² Beijing Ditan Hospital, Capital Medical University, Beijing, PR China.
³ Department of Liver Transplantation, Tianjin Key Laboratory of Organ Transplantation, Tianjin First Central Hospital, Nankai University, Tianjin, PR China.
⁴ Changping Laboratory, Beijing, PR China.
⁵ Biomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing, PR China.
⁶ School of Life Sciences, Peking University, Beijing, PR China.
⁷ Peking-Tsinghua Center for Life Sciences, Tsinghua University, Beijing, PR China.
⁸ Infection Management Office, Tianjin First Central Hospital, Nankai University, Tianjin, PR China.
⁹ Nursing Department, Tianjin First Central Hospital, Nankai University, Tianjin, PR China.
¹⁰ Intensive Care Unit, Emergency Medical Research Institute, Tianjin First Central Hospital, Nankai University, Tianjin, PR China.
¹¹ Department of Thoracic Surgery, The Fourth Hospital of Inner Mongolia, Hohhot, PR China.
¹² Organ Transplant Center, NHC Key Laboratory for Critical Care Medicine, Tianjin First Central Hospital, Nankai University, Tianjin, PR China.

No abstract available